经皮肺动脉瓣植入术的现状及未来展望  

Current situation and future prospect of percutaneous pulmonary valve implantation

作　　者：胡运洁 李永兴 于筠琛 侯文明 HU Yun-jie;LI Yong-xing;YU Jun-chen;HOU Wen-ming(Department of Cardiovascular Surgery,Affiliated Hospital of Weifang Medical University,Weifang 261031,Shandong,China)

机构地区：[1]潍坊医学院附属医院心外科,山东潍坊261031

出　　处：《心脏杂志》2022年第6期723-726,共4页Chinese Heart Journal

摘　　要：近年来,随着医学技术的进步,接受经皮肺动脉瓣植入术的患者数量不断增加,目前经皮肺动脉瓣植入术(PPVI)被认为是一种安全、有效、被国内外广泛接受的治疗患有右室流出道(RVOT)功能障碍的新方法。现临床主要应用Melody瓣膜、Sapien瓣膜和Venus-P瓣膜,依据RVOT直径大小选用不同的瓣膜。术后并发症主要包括支架断裂、感染性心内膜炎、冠状动脉及主动脉狭窄、瓣膜栓塞、肺动脉阻塞等。现就经皮肺动脉瓣植入术的现状及未来展望做一综述,以期为临床治疗提供一定的理论依据。With the progress of medical technology,the number of patients receiving percutaneous pulmonary valve implantation(PPVI)has been increasing in recent years.At present,PPVI is considered to be a safe,effective and widely accepted new method for the treatment of RVOT dysfunction at home and abroad.Now,the Melody valve,the Sapien valve and the Venus-P valves are mainly used clinically,and different valves are selected according to the RVOT diameter size.Postoperative complications mainly include stent fracture,infectious endocarditis,coronary artery and aortic stenosis,valve embolism,pulmonary artery obstruction,etc.T his article reviews the current situation and future prospect of percutaneous pulmonary valve implantation in order to provide some theoretical basis for clinical treatment.

关 键 词：经皮肺动脉瓣植入 右室流出道障碍 肺动脉瓣 未来展望 

分 类 号：R654.2[医药卫生—外科学]